Skip to content

Caring for the Geriatric Patient

Chapter 489 | Part 18: Aging · Parts 17-18 – Global Medicine & Aging · Chapter 489


Key Clinical Points

  1. Aging is not a disease; normal aging changes do not cause symptoms but increase susceptibility to illness due to diminished physiologic reserve.
  2. The '5M's of Geriatrics' (Mentation, Medication, Mobility, Multicomplexity, and Matters Most) provides a person-centered framework for care.
  3. Multimorbidity is common; nearly half of those >80 years old have three chronic conditions, and about one-third have four or more.
  4. Geriatric syndromes (e.g., falls, incontinence, delirium) are often underdiagnosed but require proactive screening using simple tools.
  5. Polypharmacy and potentially inappropriate medications (e.g., benzodiazepines, antipsychotics) must be managed via careful reconciliation and deprescribing.
  6. Comprehensive Geriatric Assessment (CGA) is essential for identifying functional impairments, social support needs, and cognitive/affective disorders.
  7. Cognitive and affective disorders are common; simple screening tools (e.g., Mini-Cog, CAM) should be used early.
  8. Driving assessment must balance the risk of accidents with the impact of social isolation; focus on identifying reversible causes like vision or hearing impairment.
  9. Foot exams are a unique component of CGA to identify mobility barriers and hygiene issues.
  10. Antimicrobials should not be used for asymptomatic bacteriuria unless specific urinary tract symptoms are present.

DEFINITION & OVERVIEW

• Aging Status: Not a disease; normal aging changes do not cause symptoms but increase susceptibility to many diseases due to diminished physiologic reserve. • Clinical Approach: Requires a comprehensive approach because acute illnesses are rarely treated in isolation but in the context of multiple comorbidities. • Demographics: Rapid growth in population >80 years; 1 in 6 people worldwide will be ≥65 by 2050.

Principles of Geriatric Care

• Multimorbidity: Conditions are often multiple and multifactorial, requiring a comprehensive approach. • Undiagnosed Conditions: Fall risk, urinary incontinence, and elder abuse/neglect are frequently under-evaluated; simple screening tools are essential. • Cognitive/Affective Status: Mild cognitive impairment, dementia, delirium, and depression are common and may be undiagnosed early. • Iatrogenic Risk: Common due to adverse drug reactions, immobility, and related deconditioning. • Goal of Care: Focus on functional ability and quality of life rather than just cure. • 5M's Framework: Organizes care in a person-centered manner: ◦ Mentation: Assessment of cognitive status (delirium, dementia, depression). ◦ Medication: Management of polypharmacy and deprescribing. ◦ Mobility: Critical for function, quality of life, and fall risk. ◦ Multicomplexity: Addressing multiple comorbidities and geriatric syndromes. ◦ Matters Most: Identifying patient goals and preferences.


EPIDEMIOLOGY

• Complexity of Care: Wide variations in aging make standard guidelines difficult; acute illnesses must be managed within the context of multiple comorbidities. • Prevalence of Comorbidity: Nearly 50% of those >80 have three chronic conditions; ≈1/3 have four or more. • Disability Prevalence: Increases with age; includes difficulty with self-care, mobility, cognition, vision, and hearing.


ETIOLOGY & PATHOPHYSIOLOGY

• Diagnostic Interpretation: Results must be interpreted cautiously due to large variations in normal aging. • Cardiac Monitoring: Arrhythmias must be linked to symptoms/outcomes before considering potentially toxic medications or invasive procedures. • Imaging Findings: ≈20% of incidental findings in the colon, extracolonic structures, ovary, and thyroid gland are malignant; many others are benign. • Routine Labs: Abnormalities in hemoglobin, thyroid function, creatinine clearance (age/sex/weight-adjusted), and LFTs are not results of normal aging but indicate underlying disorders.

Normal Aging vs. Disease

• Symptomless Changes: Normal aging does not cause symptoms but reduces physiologic reserve.


CLINICAL FEATURES

• Geriatric Syndromes: Focus on falls and incontinence as key indicators of multicomplexity. • Foot Examination: Unique component of CGA to identify barriers to independence. • Cognitive/Affective Disorders: Common; require screening for depression (sadness, loss of pleasure) and delirium (CAM).

Foot Examination

• Physical Barriers: Identify improper footwear or painful deformities. ◦ Lack of socks → may indicate difficulty due to hip arthritis or other condition. ◦ Toenail status: Poorly trimmed/fungal nails suggest lack of access to podiatry or help. • Hygiene: Inspection between toes is critical for detecting poor hygiene or ulcers (especially in diabetics).

Driving Assessment

• Risk vs. Benefit: Driving is essential for independence; assessment must focus on reversible causes like vision/hearing impairment. • Assessment Focus: Evaluate sensory (vision/hearing), functional, and cognitive impairments. • Medication Risks: Avoid antianxiety agents, narcotic analgesics, antipsychotics, anticonvulsants, and drugs with strong anticholinergic properties in patients who must drive.


DIFFERENTIAL DIAGNOSIS

• Iatrogenic Illnesses: Often caused by adverse drug reactions, immobility, and deconditioning. • Geriatric Syndromes: Fall risk and urinary incontinence are primary considerations.


DIAGNOSTIC APPROACH

  1. Comprehensive Geriatric Assessment (CGA): Used as a 'geriatric review of systems' to identify functional impairments, social support needs, and cognitive/affective disorders.
  2. Screening Tools: Use validated tools for: ◦ Depression (e.g., Geriatric Depression Scale). ◦ Cognition (e.g., Mini-Cog). ◦ Delirium (Confusion Assessment - CAM).
  3. Specific Screening (Table 489-3): • Colorectal: FIT/Sigmoidoscopy/Colonoscopy; stop if life expectancy <10 years. • Mammography: Every 1–2 years for women 50–74. • Cervical: Pap/HPV every 3–5 years until age 65. • Lung: Low-dose CT for high-risk smokers (30+ pack-year history). • Prostate: PSA screening; stop if age ≥70 (USPSTF) or if severe comorbidity exists (ACS). • Bone Density: DEXA for women ≥65. • Cardiovascular: Carotid ultrasound (age >65 + risk factors), Coronary Calcium Score (not for known CAD), and Abdominal Aortic Aneurysm (men 65–75 who ever smoked). • Metabolic: Annual glucose testing; note that evidence to screen for diabetes after age 70 is lacking.

CGA Screening Tools (Table 489-2)

• Social Support: Ask if living alone or having a caregiver → refer to social worker/agency on aging. • Elder Abuse: Ask about safety and theft → refer to adult protective services. • Advance Directives: Offer info on Power of Attorney/Living Wills. • Functional Status: Assess help needed for shopping, finances, bathing → use ADL scales. • Fall Risk: Ask about falls in past year or fear of falling → Get Up and Go test; PT evaluation. • Continence: Ask about bladder issues/pads → 3IQ (women) or AUA 7 symptom inventory (men). • Weight Loss: Check if weight <100 lbs or loss ≥10 lbs in 6 months → refer to dietician. • Sleep: Assess daytime sleepiness/nighttime difficulty → Epworth Sleepiness Scale or Pittsburgh Sleep Index. • Cognition: Screen for memory loss, Mini-Cog (3-item recall + Clock Draw), and CAM for delirium.


MANAGEMENT & TREATMENT

  1. Medication Management (Table 489-7): • Evaluate all conditions that benefit from, are harmed by, or influence drug efficacy. • Manage non-drug conditions where possible. • Use Cockcroft-Gault formula for renal adjustment: $(140 - ext{age}) imes ext{bodyweight(kg)} / (72 imes ext{serumcreatinine level})$ (multiply by 0.85 for women). • Start with smaller doses and increase gradually. • Simplify regimens, use consistent schedules, and provide clear instructions to caregivers.
  2. Fall Management (Flowchart 2): • Step 1: Ask all patients about falls in the past year. • Step 2: If "No" → Recommend prevention, education, and exercise program (gait, balance, coordination, strength). • Step 3: If "≥ 1 fall, or difficulty with gait or balance, or seeking medical attention because of fall": ◦ Check for gait or balance problems. ◦ If "One fall past 6 months" OR "No problem" → Proceed to Multifactorial risk assessment → Reassess periodically. • Interventions: Modify medications; prescribe exercise; treat vision problems; manage heart rate/rhythm; supplement Vitamin D; address postural hypotension; reduce environmental hazards; education/training in self-management and behavioral changes.
  3. Delirium Management (Table 489-8): • Drugs: Discontinue or substitute high-risk drugs; check for withdrawal from other meds. • Environment: Adequate lighting, reduced noise, reorient patient frequently. • Other: Treat infections, correct hypoxemia, treat urinary retention/fecal impaction, and provide physical/occupational therapy.
  4. Incontinence Management (Table 489-10 & 12): • Urinary Tract Infection: Antimicrobial therapy. • Atrophic Vaginitis: Topical estrogen (to reduce infection). • Stool Impaction: Disimpaction and laxatives. • Stress Incontinence: Pelic muscle exercises, timed voiding, α-Adrenergic agonists, or surgical options. • Urge/Mixed: Bladder training, double voiding, or β-3-adrenergic drugs.
  5. Sleep Management (Table 489-13): • Sleep Hygiene: Avoid caffeine/alcohol after lunch; limit liquids in evening; regular sleep schedule; limit naps to <30 min. • Stimulus-Control: Only go to bed when sleepy; if awake for >20 min, get out of bed and do something quiet until sleepy again.

Hypertension Management

• Target Selection: HYVET supports treatment in patients >80 years if SBP ≥160 mmHg; SPRINT suggests intensive control may reduce dementia risk in selected patients.

Diabetes Medication (Table 489-4)

• Metformin: First-line agent; safe for eGFR ≥30 mL/min/1.73 m²; use caution in advanced renal failure or heart failure. • Thiazolidinediones: Use cautiously in those at risk for heart failure, falls, or fractures. • DPP-4 Inhibitors: Few side effects and minimal hypoglycemia.


COMPLICATIONS & PROGNOSIS

• Life Expectancy: Screening for chronic diseases (e.g., colon cancer) is not recommended if life expectancy is <10 years due to risk of overdiagnosis. • Care Transitions (Table 489-15): Utilize programs like Project RED or Care Transitions Program to ensure medication reconciliation and coordination with primary care providers.


SPECIAL CONSIDERATIONS

• Elder Abuse & Neglect (Table 489-14): ◦ Physical: Look for bruises, fractures, or signs of restraint. Interview patient alone. ◦ Financial: Check for inability to pay for meds/food or sudden changes in caregiver's finances. ◦ Neglect: Identify malnutrition, dehydration, and poor hygiene.


KEY PEARLS & CLINICAL TRAPS

• Fall Management: If a patient has ≥1 fall in the past year or difficulty with gait/balance, perform a multi-factorial risk assessment. • Medication Safety: Avoid benzodiazepines and antipsychotics as first-line treatments for insomnia or agitation due to fall and cognitive risks. • Incontinence Differentiation: Use 3IQ to distinguish between Stress (physical activity), Urge (sudden urge), and Mixed types.


Reference Tables

Table 489-1 . of Geriatric Assessment addresses all of the components required for conditions and syndromes in older…

Harrison's 22e, p.3877

1
9
5
23
5
3
6
9
7
1

TABLE 489-2 Examples of Screening Questions and Tools and Strategies for Further Evaluation of Social Support…

Harrison's 22e, p.3879

GERIATRIC ASSESSMENT DOMAINS RECOMMENDED SCREENS FURTHER ASSESSMENT FOR POSITIVE SCREEN
LAICOS Social Support Do you live alone?
Do you have a caregiver?
Are you a caregiver?
• Consider referral to a social worker
• Refer to area agency on aging
Elder Neglect/Abuse Do you ever feel unsafe where you live?
Has anyone ever threatened or hurt you?
Has anyone been taking your money without your
permission?
• Consider referral to a social worker and/or adult
protective services
Advance Directives Would you like information or forms for a power of attorney
for health care?
Would you like information on a living will?
• Discussion on advance directives
• Physician Orders for Life-Sustaining Treatment (POLST)
(or MOLST or POST)
Functional Status Do you need assistance with shopping or finances?
Do you need assistance with bathing or taking a shower?
Driving Do you still drive? If yes:
While driving, have you had an accident in the past
6 months?
Driving concerns by family member?
Vision Do you have trouble seeing, reading, or watching TV? (with
glasses, if used)
Hearing Do you have difficulty hearing conversation in a quiet
room?
Unable to hear whisper test 6 inches away?
SEMORDNYS
CIRTAIREG
Medications Do you take five or more routine medications?
Do you understand the reason for each of your
medications?
• Match medications with diagnoses
• Consider reducing doses, stopping drugs, adherence
aides, and/or consultation with a pharmacist
Fall Risk Have you fallen in the past year?
Are you afraid of falling?
Do you have trouble climbing stairs or rising from chairs?
• “Get Up and Go” test
• Consider full fall assessment
• Consider physical therapy evaluation
• Consider home safety assessment
Continence Do you have any trouble with your bladder?
Do you lose urine or stool when you do not want to?
Do you wear pads or adult diapers?
• Consider full continence assessment
• 3IQ Questionnaire (women)
• AUA 7 symptom inventory (men)
Weight Loss Weight <100 pounds or
Unintentional weight loss ≥10 pounds over 6 months?
• Assess for common risk factors for malnutrition
• Consider referral to dietician for nutritional evaluation
Sleep Do you often feel sleepy during the day?
Do you have difficulty falling asleep at night?
• Epworth Sleepiness Scale or Pittsburgh Sleep Index
• Consider referral for sleep evaluation
Pain Are you experiencing pain or discomfort? • Pain assessment
Alcohol Abuse Do you drink >2 drinks/day? • AUDIT-C
Depression Do you often feel sad or depressed?
Have you lost pleasure in doing things over the past few
months?
Cognition Self-reported memory loss?
Cognitive screen positive? (three-item recall and Clock
Draw test “Mini-Cog”)
Confusion Assessment (CAM) for delirium

TABLE 489-3 Recommendations for Primary Prevention Screening for Specific Diseases in Older Adults from Different…

Harrison's 22e, p.3881

TYPE OF
SCREENING
TEST FREQUENCY PROFESSIONAL SOCIETY ISSUING RECOMMENDATIONS
USPSTFa ACSb ACPc
Colorectal Fecal occult
blood test or fecal
immunochemical test
(FIT) or
Sigmoidoscopy or
Colonoscopy
Annual
Every 5 y
Every 10 y
Screen all adults age 50–75; prognosis
may support screening individuals
of age 76–85 if never screened; not
recommended for adults over age 85
Screen all adults age >50;
discontinuing screening is
reasonable in people with
severe comorbidity that
would preclude treatment
Screen all adults age 50–75
People with life expectancy
<10 y should not be
screened
Mammography Every 1–2 y Biennial screening of all women age
50–74; evidence of benefits and harms
is insufficient for women age >75
Annual screening starting
at age 40; continue while
in good health
ECOGd
Cervical Pap smear
HPV test
Pap only, every 3 y
HPV + Pap, every 5 y
Screen women age 21–65; discontinue
at age 65 if adequate prior screening
Screen women age 21–65;
discontinue at age 65;
discontinue at age 65 if
regular screening normal
Screening should stop
at age 65 if evidence of
negative adequate prior
screening
Low-dose CT scan Annual Screen age 55–80 current and former
smokers with a 30+ pack-year smoking
history; discontinue screening once a
person has not smoked for 15 years or
develops a health problem that limits
their ability or willingness to have
curative surgery
Screen 55–74-y-old
current and former
smokers in good health
with a 30+ pack-year
smoking history
ACCPe
Prostate Prostate-specific
antigen (PSA)
1–2 y Do not screen men for prostate cancer
with PSA if age 70 y or older
Screen men age 50
and over with a life
expectancy >10 y after
discussion about the
risks, benefits, and
uncertainties of PSA
screening
Follow-up screening
should occur annually
if PSA >2.5 ng/mL or
biennially if PSA
<2.5 ng/mL
AUAf
Biennial PSA screening in
men age 55–69 y with life
expectancy >10–15 y, after
shared decision-making
discussions accounting for
values and preferences
Dual-energy x-ray
absorptiometry (DEXA)
Measure height,
preferably with a wall-
mounted stadiometer
Perform bone mineral
density testing
1–2 y after initiating
medical therapy for
osteoporosis and
every 2 y annually
thereafter
USPSTFa NOFg
Screen women age 65; the current
evidence is insufficient to assess
the balance of benefits and harms of
screening for osteoporosis to prevent
osteoporotic fractures in men
Carotid disease Carotid ultrasound Once SOCIETY OF VASCULAR SURGERY
Age over 65, coronary artery disease, need for coronary bypass, symptomatic lower extremity
arterial occlusive disease, history of tobacco use, and high cholesterol would be appropriate risk
factors to prompt ultrasound in patients with a bruit
Coronary calcium
score (CCS)
Once SCCTh AHA/ACCi
Do not use CCS for patients with known
CAD
Abdominal
aortic aneurysm
Abdominal ultrasound Once USPSTFa AAFPj
The USPSTF recommends one-time
screening for abdominal aortic
aneurysm with ultrasonography in men
aged 65–75 y who have ever smoked;
there is insufficient evidence to
recommend screening for women even
if they have ever smoked
Recommended for men aged 65–75 y who have ever
smoked
Fasting blood glucose,
glucose tolerance test,
or hemoglobin A
1c
Annually USPSTFa ADAk
No evidence to screen for diabetes
after the age of 70; recommendation
being reviewed at the time of this
publication

TABLE 489-4 Recommendations and Considerations for Pharmacologic Therapy of Diabetes in Older Adults MEDICATION…

Harrison's 22e, p.3882

MEDICATION RECOMMENDATIONS AND CONSIDERATIONS
Metformin • Metformin is the first-line agent for older adults with
type 2 diabetes
• Low risk of hypoglycemia
• Recent studies suggest it may be used safely in patients
with estimated glomerular filtration rate ≥30 mL/
min/1.73 m2
• Use with caution in patients with advanced renal
insufficiency or significant heart failure
• Can cause gastrointestinal symptoms with lower
appetite
Thiazolidinediones • If used at all, should be used very cautiously in those
with, or at risk for, congestive heart failure and those at
risk for falls or fractures
Dipeptidyl peptidase
4 (DPP-4) inhibitors
• Few side effects and minimal hypoglycemia, but costs
may be a barrier
• No evidence of increase in major adverse
cardiovascular events

TABLE 489-5 Evaluating the Older Person Who Falls—Immediate Postfall Evaluation History • Circumstances surrounding the…

Harrison's 22e, p.3886

  • History
  • • Circumstances surrounding the fall
    • Relationship to changes in posture, turning of head, after a meal or medication intake, rushing to the toilet, nocturia, straining to urinate or defecate
    • Accidental trip or slip (note that many correctable factors can contribute to a reported “mechanical” fall—see text)
    • Hazards in the living environment (loose rugs, cords, unsafe steps, slippery floors, etc.)
    • Premonitory or associated symptoms
    • Dizziness (lightheadedness vs vertigo); cardiovascular (postural lightheadedness, palpitations, chest pain, shortness of breath); focal neurologic symptoms
    suggestive of stroke or transient ischemic attack (weakness, sensory disturbance, dysarthria, ataxia, aphasia); symptoms of a seizure (witnessed clinic
    movements, incontinence of urine or stool, tongue biting)
    • Symptoms over the previous few days that may have led to volume depletion (poor food/fluid intake, nausea/vomiting, diarrhea, urinary frequency/polyuria)
    • Exclude loss of consciousness or seizure (may be difficult without a witness)
    • Medications—chronic and within the few hours before the fall
    • Diuretics and other antihypertensive drugs
    • Nitrates
    • Drugs that cause bradycardia—beta blockers; cholinesterase inhibitors
    • Psychotropics—antipsychotics, hypnotics, sedatives, antidepressants
    • Antiparkinsonian drugs
    • Hypoglycemic drugs
    • Excessive alcohol intake
  • Physical Examination
  • • Exclude physical injury
    • Head trauma, hip range of motion, pubic bone tenderness, wrist pain, other signs of trauma
    • Bruising in patients on anticoagulants/platelet inhibitors
    • Exclude acute illness
    • Vital signs
    • Postural vital signs (if feasible/safe)
    • Fingerstick glucose in diabetics
    • Poor skin turgor suggesting volume depletion (over chest; other areas unreliable)
    • Signs of an acute respiratory, cardiovascular, or abdominal condition
    • Focal neurologic signs suggestive of stroke
    • Signs of conditions that increase risk for falls
    • Poor visual acuity; use of bifocals
    • Limited range of motion of neck (to detect possible cervical arthritis/disk disease)
    • Cardiovascular—arrhythmias, carotid bruits, aortic stenosis, mitral insufficiency, heart failure
    • Degenerative joint disease in lower extremities causing pain, limited range of motion, and/or deformity
    • Podiatric conditions (calluses; bunions; ulcerations; poorly fitted, inappropriate, or unsafe shoes)
    • Neurologic signs—lower extremity muscle weakness; peripheral neuropathy; tremor, rigidity, and/or bradykinesia suggestive of undiagnosed Parkinson’s disease;
    cerebellar signs (abnormal heel to shin or heel tapping); abnormal reflexes that could reflect upper motor neuron disorder such as spinal cord compression or
    subdural hematoma; cognitive deficits that can result in poor judgement
    • Observation of gait and balance—simple Get Up and Go test (see text) with observation for short steps, poor foot elevation, wide-based gait, multiple steps to turn
    180 degrees; other abnormalities that might suggest normal pressure hydrocephalus (especially in combination with symptoms of incontinence and/or cognitive
    impairment)
  • Laboratory and/or Imaging Studies
  • • Should be guided by history and physical examination—common examples include:
    • Complete blood count, basic metabolic panel to exclude/verify acute illness
    • Urinalysis (only when additional symptoms of urinary tract infection present)
    • Electrocardiogram (in patients suspected of acute coronary syndrome or with significant known cardiovascular disease)
    • X-rays to exclude fractures
    • Brain imaging if signs present to exclude subdural hematoma, stroke
    • Cardiac monitoring in patients with history suggestive of syncope or near-syncope
    • Electroencephalography in patients with history suggestive of seizure

TABLE 489-7 General Recommendations for Geriatric Prescribing 1. Evaluate geriatric patients thoroughly to identify all…

Harrison's 22e, p.3887

CAUSES EXAMPLES OF TREATMENT
Cardiovascular
Arrhythmias Antiarrhythmic medication, ablation,
pacemaker (depending on nature of arrhythmia)

TABLE 489-7 General Recommendations for Geriatric Prescribing

1. Evaluate geriatric patients thoroughly to identify all conditions that could (a)
benefit from drug treatment; (b) be adversely affected by drug treatment;
and (c) influence the efficacy of drug treatment.
2. Manage medical conditions without drugs as often as possible.
3. Know the pharmacology of the drug(s) being prescribed.
4. Consider how the clinical status (e.g., renal function, hydration) of each
patient could influence the pharmacology of the drug(s).
5. Avoid potentially serious adverse drug-drug interactions.
6. For drugs or their active metabolites eliminated predominantly by the kidney,
use a formula to approximate age-related changes in renal function and
adjust dosages accordingly; the Cockcroft-Gault formula (below) is probably
safer as it tends to underestimate creatinine clearance.
(140−age) × bodyweight(kg)
Creatinineclearance= (×0.85forwomen)
72×serumcreatininelevel
7. If there is a question about drug dosage, start with smaller doses and
increase gradually until the drug is effective or intolerable side effects are
observed.
8. Drug blood concentrations can be helpful in monitoring several potentially
toxic drugs used in the geriatric population.
9. Help to ensure adherence by:
a. Making drug regimens and instructions as simple as possible
b. Using the same dosage schedule for all drugs whenever feasible (e.g.,
once or twice per day)
c. Timing the doses in conjunction with a daily routine
d. Paying attention to impaired cognitive function, diminished hearing, and
poor vision when instructing patients and labeling prescriptions
e. Instructing relatives and caregivers on the drug regimen
f. Enlisting other health professionals (e.g., home health aides, pharmacists)
to help ensure compliance
g. Making sure the older patient can get to a pharmacist (or vice versa), can
afford the prescriptions, and can open the container
h. Using aids (e.g., special pillboxes and drug calendars) whenever
appropriate
i. Performing careful medication adjudication and patient/family education
at the time of every hospital discharge
j. Keeping updated medication records and review them at each visit
k. Reviewing knowledge of and adherence with drug regimens regularly
10. Monitor older patients frequently for adherence, drug effectiveness, and
adverse effects, and adjust drug therapy accordingly.
Postural hypotension Reduce or eliminate hypotensive drugs
Hydration, support stockings
Medication (Proamatine [midodrine],
fludrocortisone, droxidopa)
Adaptive behaviors (e.g., pausing and getting
up slowly)
Neurologic
Autonomic dysfunction with
postural hypotension
As above
Parkinson’s disease Antiparkinsonian drugs
Seizure disorder Anticonvulsants
Dementia Supervised activities
Hazard-free environment
Others
Foot disorders Podiatric evaluation and treatment
Muscle weakness,
deconditioning
Lower extremity strength training
Vitamin D deficiency Vitamin D supplementation

TABLE 489-9 Key Principles in the Management of Dementia Optimize the patient’s physical and mental function through…

Harrison's 22e, p.3889

CONTRIBUTING
FACTORS
APPROACHES TO EVALUATION AND MANAGEMENT
Drugs Consider the etiologic role of newly initiated drugs,
increased doses, interactions, over-the-counter
drugs, and alcohol; consider especially the role of
high-risk drugs: lower the dose, discontinue the drug,
or substitute a less psychoactive medication.
Consider withdraw from chronic medications. Pay
special attention to psychotropic medications.

TABLE 489-9 Key Principles in the Management of Dementia

Optimize the patient’s physical and mental function through physical activity and
mind plasticity principles and activities
Treatment underlying medical and other conditions (e.g., hypertension,
Parkinson’s disease, depression)
Avoid use of drugs with central nervous system side effects (unless required
for management of psychological or behavioral disturbances—see Chap. 31)
Assess the environment and suggest alterations, if necessary
Encourage physical and mental activity
Avoid situations stressing intellectual capabilities; use memory aids whenever
possible
Prepare the patient for changes in location
Emphasize good nutrition
Identify and manage behavioral symptoms and complications
Driving (consider a formal driving evaluation)
Wandering
Dangerous driving
Behavioral disorders
Depression
Agitation or aggressiveness
Psychosis (delusions, hallucinations)
Malnutrition
Incontinence
Provide ongoing care
Reassessment of cognitive and physical function
Treatment of medical conditions
Provide information to patient and family
Nature of the disease
Extent of impairment
Prognosis
Provide social service information to patient and family
Local Alzheimer’s association
Community health care resources (day centers, homemakers, home health
aides)
Legal and financial counseling
Use of advance directives
Provide family counseling for:
Setting realistic goals and expectations
Identification and resolution of family conflicts
Handling anger and guilt
Decisions on respite or institutional care
Legal concerns
Ethical concerns
Consideration of palliative and hospice care
Protect the caregiver from effects of caregiver stress
Infection Urinary tract infections, pneumonia, soft tissue
infection
Urinary and fecal
disorders
Treat urinary retention and fecal impaction
Prevent or Manage Complications
Urinary incontinence Scheduled toileting
Pressure ulcers Mobility and repositioning, nutrition
Feeding disorders Feeding assistance if necessary, aspiration
precautions, liberalize diet if possible
Maintain Patient Comfort and Safety
Pharmacologic
interventions
Only if patients become a threat to themselves or
others and other interventions have failed
Restore Function
Cognitive reconditioning Reorient patient frequently
Discharge planning Assess new needs based on predischarge functional
status, evaluate social support, coordinate
transitions of care, medication reconciliation

TABLE 489-10 Reversible Conditions That Cause or Contribute to Urinary Incontinence and Overactive Bladder Symptoms in…

Harrison's 22e, p.3890

CONDITION MANAGEMENT
Lower urinary tract conditions
Urinary tract infection (symptomatic with frequency,
urgency, dysuria, etc.)
Antimicrobial therapy
Atrophic vaginitis/urethritis Topical estrogen (not a primary treatment for incontinence but may help prevent recurrent infections and
ameliorate symptoms of overactive bladder; oral estrogens can cause or worsen incontinence)
Stool impaction with irritation of bladder/urethral
innervation and/or partial bladder outlet obstruction
Disimpaction; appropriate use of stool softeners, bulk-forming agents, and laxatives if necessary; implement
bowel regimen
Impaired ability or willingness to reach a toilet
Delirium Diagnosis and treatment of underlying cause(s)
Chronic illness, injury, or restraint that interferes with
mobility
Regular toileting
Use of toilet substitutes
Environmental alterations (e.g., bedside commode, urinal)
Remove restraints if possible
Psychological (depression, anxiety) Appropriate nonpharmacologic and/or pharmacologic treatment

TABLE 489-11 Key Aspects of the History and Physical Examination of an Older Patient with Symptoms of Urinary…

Harrison's 22e, p.3892

  • History
  • Active medical conditions, especially neurologic disorders, diabetes mellitus, congestive heart failure, venous insufficiency
    Medication review for drugs that can contribute (see Table 489-10)
    Fluid intake pattern
    Type and amount of fluid (especially caffeine and fluids before bedtime)
    Past genitourinary history, especially childbirth, surgery, dilatations, urinary retention, recurrent urinary tract infections
    Symptoms of incontinence
    Onset and duration
    Type—stress vs urge vs mixed vs other (see Fig. 489-10)
    Frequency, timing, and amount of incontinence episodes and of continent voids (a voiding diary may be useful)
    Other lower urinary tract symptoms
    Irritative—dysuria, frequency, urgency, nocturia
    Voiding difficulty—hesitancy, slow or interrupted stream, straining, incomplete emptying
    Other—hematuria, suprapubic discomfort
    Other symptoms
    Neurologic (indicative of stroke, dementia, parkinsonism, normal-pressure hydrocephalus, spinal cord compression, multiple sclerosis)
    Psychological (depression)
    Bowel (constipation, stool incontinence)
    Symptoms suggestive of volume-expanded state (e.g., lower extremity edema, shortness of breath while horizontal or with exertion)
    Environmental factors
    Location of bathroom
    Availability of toilet substitutes (e.g., urinal, bedside commode)
    Perceptions of incontinence
    Patient’s concerns or ideas about underlying cause(s)
    Most bothersome symptom(s)
    Interference with daily life
    Severity (e.g., “Is it enough of a problem for you to consider surgery?”)
  • Physical Examination
  • Mobility and dexterity
    Functional status compatible with ability to self-toilet
    Gait disturbance (e.g., that may suggest parkinsonism, normal-pressure hydrocephalus)
    Mental status
    Cognitive function compatible with ability to self-toilet
    Motivation
    Mood and effect
    Neurologic
    Focal signs (especially in lower extremities) that could suggest a central nervous system condition
    Signs of parkinsonism
    Sacral arc reflexes (e.g., loss of perianal sensation or an anal wink in response to perianal stimulation)
    Abdominal
    Bladder distensiona
    Suprapubic tenderness
    Lower abdominal mass
    Rectal
    Perianal sensation
    Sphincter tone (resting and active)
    Impaction
    Masses
    Size and contour of prostate (neither is diagnostic of urethral obstruction)
    Pelvic
    Perineal skin condition
    Perineal sensation
    Atrophic vaginitis (friability, inflammation, bleeding)
    Pelvic prolapse or mass
    Other
    Lower extremity edema or signs of congestive heart failure (if nocturia is a prominent complaint)

TABLE 489-12 Primary Treatments for Different Types of Geriatric Urinary Incontinence

Harrison's 22e, p.3893

TYPE OF
INCONTINENCE
PRIMARY TREATMENTS
Stress Pelvic muscle (Kegel) exercises
Other behavioral interventions including timed voiding
and double voiding to avoid residual urine
α-Adrenergic agonist (none are approved by the U.S.
Food and Drug Administration for this purpose)
Topical estrogen to strengthen periurethral tissue (not
effective alone; oral estrogens contraindicated)
Periurethral injections to provide bulking and support
Surgical bladder neck suspension or sling for severe
incontinence, based on patient preference
Incontinence with
incomplete bladder
emptying
α-Adrenergic antagonists in men with a 5α-reductase
inhibitor if the prostate is enlarged); an antimuscarinic
or β-3-adrenergic drug can be added if unresponsive to
the α-adrenergic agonist
Bladder training, double voiding
Intermittent catheterization
Indwelling catheterization in selected patients in whom
risks and discomforts of urinary retention outweigh
risks of a chronic indwelling catheter

TABLE 489-13 Nonpharmacologic Management of Insomnia in Older Adults Sleep Hygiene Rules Check effect of medication on…

Harrison's 22e, p.3894

  • Sleep Hygiene Rules
  • Check effect of medication on sleep and wakefulness
  • Avoid caffeine, alcohol, and cigarettes after lunch
  • Limit liquids in the evening
  • Keep a regular bedtime-waketime schedule
  • Avoid naps or limit to 1 nap a day, no longer than 30 min
  • Spend time outdoors (without sunglasses), particularly in the late afternoon or
    early evening
  • Exercise—but limit exercise immediately before bedtime
  • Instructions for Stimulus-Control Therapy
  • Only go to bed when tired or sleepy
  • If unable to fall asleep within 20 min, get out of bed (and bedroom if possible);
    while out of bed, do something quiet and relaxing
  • Only return to bed when sleepy
  • If unable to fall asleep within 20 min, again get out of bed
  • Repeat these behaviors until able to fall asleep within a few minutes
  • Get up at the same time each morning (even if only a few hours of sleep)
  • Avoid naps

TABLE 489-14 Elder Abuse and Neglect CATEGORY Physical abuse

Harrison's 22e, p.3895

CATEGORY DEFINITION AND EXAMPLES SYMPTOMS AND SIGNS KEY ASPECTS OF EVALUATION
Physical abuse Acts of violence that may result
in pain, injury, or impairment
• Pushing, slapping, hitting,
force-feeding
• Improper positioning or use
of restraints
• Improper use of medications
Abrasions
Lacerations
Bruises
Fractures
Use of restraints
Burns
Pain
Depression
Delirium or onset or worsening of
dementia-related behavioral symptoms
The interview should be conducted alone with the patient; it may
reveal discordant histories or findings inconsistent with the history
provided by the caregiver.
Ankles and wrists should be examined for abrasions suggestive of the
use of restraints.
Findings that are discordant with the mechanism of injury reported
or multiple injuries in various stages of healing should raise the
suspicion of abuse.
Injuries to the head, neck, and upper arms occur in victims of physical
elder abuse but must be distinguished from accidental injuries.
Jaw and zygomatic fractures are more likely to be sustained from
a punch than from a fall, which more typically result in fractures to
orbital and nasal bones.
Conduct that causes mental or
emotional distress
• Verbal harassment or
intimidation
• Threats of punishment or
deprivation
• Isolation
Direct observation of verbal abuse
Subtle signs of intimidation, such as
deferring questions to a caregiver or
potential abuser
Evidence of isolation
Depression, anxiety, or both
Financial abuse Misuse of the person’s income
or resources for the financial
or personal gain of a caregiver
or advisor
• Stealing money or
possessions
• Denying a home
• Coercing to sign contracts or
spend money
Inability to pay for medicine, medical care,
food, rent, or other necessities
Failure to renew prescriptions, adhere to
medication regimens or other treatments,
or keep medical appointments
Malnutrition, weight loss, or both, without
an obvious medical cause
Evidence of poor financial decision-making
Firing of home care or other service
providers by abuser
Unpaid utility bills
Initiation of eviction proceedings
Ask about financial exploitation with questions such as, “Has money
or property been taken from you without your consent?”; “Have your
credit cards or automated teller machine card been used without
your consent?”; and “At the end of the month, do you have enough
money left for food and other necessities?”
Abrupt changes in financial circumstances of the caregiver in either
direction may herald an increased risk of financial exploitation or
exploitation already under way.
Abuse of the power of attorney; if the person with power of attorney
or health care proxy is suspected of not acting in the best interest of
the patient, documents necessary to ensure that the assumption of
fiduciary responsibilities is authorized.
Sexual coercion or assault Bruising, abrasions, lacerations in the
genital or anal areas or abdomen
Newly acquired sexually transmitted
diseases, especially in nursing home
Urinary tract infection
Neglect (by
caregiver or
self-neglect)
Failure to provide the materials,
supplies, food and drink, or
services necessary for optimal
functioning or to avoid harm
Malnutrition
Dehydration
Poor hygiene
Pressure ulcers
Nonadherence to medication regimen or
other treatments
Worsening of dementia-related behavioral
symptoms
Interview primary caregiver about their understanding of the nature
of the patient’s care needs and how well care is being rendered.
Neglect by a caregiver may be intentional or unintentional.
Assess hygiene, cleanliness, and appropriateness of dress.
Examine the skin for pressure ulcers, infections, and infestations.
Assess nutrition and hydration, including measuring body mass index
and blood urea nitrogen and creatinine to assess hydration.

TABLE 489-15 Examples Care Transitions Interventions INTERVENTION Re-Engineered Discharge (Project RED) (Jack et al…

Harrison's 22e, p.3896

INTERVENTION WEBSITE CORE INTERVENTIONS
Re-Engineered Discharge
(Project RED)
(Jack et al: 2009)
https://www.bu.edu/fammed/
projectred/
“Discharge advocate” performs the following:
• Facilitates patient education and understanding
• Performs medication reconciliation
• Coordinates postdischarge appointments and communication with primary care provider (PCP)
• Calls patient 2–3 days after discharge
https://www.nursing.
upenn.edu/ncth/
transitional-care-model/
Care Transitions Program®
(Coleman et al: 2004)
http://www.caretransitions.
org
“Transition coach” performs the following:
• Facilitates improved self-management skills including medication management and how to
respond to warning signs/symptoms
• Makes postdischarge home visits and phone calls
https://www.
hospitalmedicine.org/
clinical-topics/
care-transitions/
Interventions to Reduce Acute
Care Transfers (INTERACT)
(Ouslander et al: 2013)
http://www.interact-pathway.
com
Includes tools for skilled nursing, assisted living, and home health care, including:
• Quality improvement
• Communication
• Decision support
• Advance care planning